Sun Kim

Sun Kim has extensive work experience in various roles and industries. Currently, Sun is the Executive Vice President of the Bio/Health Care Industry at Samsung Global Research. Prior to this, Sun worked as the Chief Commercial Officer and Chief Strategy & Investor Relations Officer at CENTOGENE, where they played a key role in establishing corporate strategy and navigating through the NASDAQ listing. Before that, Sun held positions at Shire as the Head of Corporate Strategy and VP of Investor Relations. Additionally, Sun was the Global Head of Business Service Excellence at Novartis, the General Manager and Global Head of Strategy at Alcon Laboratories, and the Director of Global Strategy and Global Head of the Generics Franchise at Bausch & Lomb. Sun also gained consulting experience at McKinsey & Co and A.T. Kearney. Sun began their career as a Senior Research Engineer at LG Semicon.

Sun Kim has a Ph.D. in Chemical Engineering from Stanford University. They also have a B.S. in Chemical Engineering from Seoul National University. Sun Kim has completed the Novartis Business Finance II program at Harvard Business School Executive Education.